Growth Metrics

Zoetis (ZTS) Receivables - Other (2016 - 2025)

Zoetis (ZTS) has disclosed Receivables - Other for 10 consecutive years, with $79.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Receivables - Other rose 36.21% to $79.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $79.0 million, a 36.21% increase, with the full-year FY2024 number at $79.0 million, up 36.21% from a year prior.
  • Receivables - Other was $79.0 million for Q4 2024 at Zoetis, up from $58.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $79.0 million in Q4 2024 to a low of $47.0 million in Q4 2021.
  • A 5-year average of $60.6 million and a median of $58.0 million in 2023 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: soared 51.06% in 2022, then fell 18.31% in 2023.
  • Zoetis' Receivables - Other stood at $48.0 million in 2020, then fell by 2.08% to $47.0 million in 2021, then soared by 51.06% to $71.0 million in 2022, then dropped by 18.31% to $58.0 million in 2023, then surged by 36.21% to $79.0 million in 2024.
  • Per Business Quant, the three most recent readings for ZTS's Receivables - Other are $79.0 million (Q4 2024), $58.0 million (Q4 2023), and $71.0 million (Q4 2022).